These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5724370)

  • 81. A comparison of the biological activity of uracil mustard and Dopan.
    PETERING HG; BUSKIRK HH; MUSSER EA; EVANS JS
    Cancer Chemother Rep; 1963 Mar; 27():1-10. PubMed ID: 13942713
    [No Abstract]   [Full Text] [Related]  

  • 82. [Cross resistance studies in degranol resistant NK-ly ascites tumors].
    Gáti E
    Z Krebsforsch; 1966; 68(2):184-9. PubMed ID: 4228637
    [No Abstract]   [Full Text] [Related]  

  • 83. Antitumor agents. Schiff bases from benzaldehyde nitrogen mustards and 2-phenyl-4-((3-amino-4-methoxy)phenyl)thiazole.
    Modi JD; Sarnis SS; Deliwala CV
    J Med Chem; 1971 May; 14(5):450-1. PubMed ID: 5117694
    [No Abstract]   [Full Text] [Related]  

  • 84. EFFECTS OF URACIL MUSTARD ON INCORPORATION OF L-LYSINE-U-14C INTO ACIDIC NUCLEOLAR PROTEINS OF THE WALKER TUMOR AND LIVER.
    DESJARDINS R; BUSCH H
    Tex Rep Biol Med; 1964; 22():444-53. PubMed ID: 14221508
    [No Abstract]   [Full Text] [Related]  

  • 85. [Mechanism of action of pafencil on sensitive and resistant tumor cells].
    Ivanova LE; Kotel'nikov VM
    Gematol Transfuziol; 1992 Mar; 37(3):37-9. PubMed ID: 1516801
    [No Abstract]   [Full Text] [Related]  

  • 86. Potential carcinolytic agents. IV. Diazoamino mustards.
    Papanastassiou ZB; Bruni RJ; White E; Levins V; Levins PL
    J Med Chem; 1966 Sep; 9(5):725-9. PubMed ID: 5969046
    [No Abstract]   [Full Text] [Related]  

  • 87. Quantitative structure-activity relationships in immunosuppressive nitrogen mustard benzimidazoles.
    Franke R; Zschiesche W; Augsten K; Güttner J; Hesse G
    J Reticuloendothel Soc; 1974 Aug; 16(2):87-95. PubMed ID: 4455897
    [No Abstract]   [Full Text] [Related]  

  • 88. Aryl-2-halogenoalkylamines. XXVI. Glucuronic, sulphuric and phosphoric esters of p-di-2-chloroethylaminophenol.
    Bukhari MA; Everett JL; Ross WC
    Biochem Pharmacol; 1972 Apr; 21(7):963-7. PubMed ID: 5039754
    [No Abstract]   [Full Text] [Related]  

  • 89. Evaluation of antileukemic agents employing advanced leukemia L-1210 in mice. VI.
    GOLDIN A; VENDITTI JM; KLINE I
    Cancer Res; 1962 Sep; 2():749-835. PubMed ID: 13948731
    [No Abstract]   [Full Text] [Related]  

  • 90. [Studies on treatment with antitumor agents--short-term observations on the effects in vitro].
    Katsuta K; Hisatsune K; Kajiyama M; Miyahara H; Atsumi T
    Iryo; 1967 Oct; 21(10):1183-92. PubMed ID: 5590371
    [No Abstract]   [Full Text] [Related]  

  • 91. Variable drug sensitivity and chromosomal features of a cancer clone.
    Isaka H
    Gan; 1965 Oct; 56(5):443-60. PubMed ID: 4285078
    [No Abstract]   [Full Text] [Related]  

  • 92. [The antiblastomatous activity of 9-methyladenine, 1-methyluracil and 1-methylthymine].
    Kolosov AI
    Vopr Onkol; 1975; 21(5):116-7. PubMed ID: 1210140
    [No Abstract]   [Full Text] [Related]  

  • 93. THERAPEUTIC EFFECT OF ANTICANCER DRUGS ON SKIN CANCER.
    HIGUCHI K; UEMATSU K
    Kyushu J Med Sci; 1963 Oct; 14():203-9. PubMed ID: 14104458
    [No Abstract]   [Full Text] [Related]  

  • 94. [SPECTROPHOTOMETRIC DETERMINATION OF CYTOSTATICS FROM THE DICHLOROETHYLAMINE GROUP (DOPAN AND SARCOLYSIN) IN THE ULTRAVIOLET RANGE].
    BLAZHEK IIa; KRACHMAR I
    Farm Zh; 1965; 20():22-5. PubMed ID: 14348007
    [No Abstract]   [Full Text] [Related]  

  • 95. [A CASE OF ACUTE POISONING WITH DOPAN].
    BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM
    Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983
    [No Abstract]   [Full Text] [Related]  

  • 96. [Treatment of various nephropathies by nitrogen mustard and antimetabolites].
    Milliez P; Lagrue G; Bariety J
    Tunis Med; 1970; 48(1):39-43. PubMed ID: 5509548
    [No Abstract]   [Full Text] [Related]  

  • 97. Attempts to use albumin as a carrier of L-phenylalanine mustard.
    Larsen B
    Eur J Cancer (1965); 1967 Jun; 3(2):163-4. PubMed ID: 6046496
    [No Abstract]   [Full Text] [Related]  

  • 98. Boron hydride anions. I. Nitrogen mustards.
    Haslinger F; Soloway AH; Butler DN
    J Med Chem; 1966 Jul; 9(4):581-4. PubMed ID: 5968027
    [No Abstract]   [Full Text] [Related]  

  • 99. Potential anticancer agents. Synthesis of aromatic nitrogen mustards containing an azo group.
    Sugimoto K; Oki S
    Chem Pharm Bull (Tokyo); 1964 Nov; 12(11):1375-8. PubMed ID: 5888645
    [No Abstract]   [Full Text] [Related]  

  • 100. Synthesis and screening of substances acting by alkylation and metabolic inhibition.
    De Barbieri A
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):67-77. PubMed ID: 5659737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.